CAUTI Reduction Guidelines and Recommendations


  • Centers for Disease Control and Prevention

     

    2009 CAUTI Prevention Guidelines

     

    Recommendations on Foley Catheter Materials

    If the CAUTI rate is not decreasing after implementing a comprehensive strategy to reduce rates of CAUTI, consider using antimicrobial/antiseptic-impregnated catheters. The comprehensive strategy should include, at a minimum, the high priority recommendations for urinary catheter use, aspetic insertion, and maintenance (Category IB).


    Association for Professionals in Infection Control and Epidemiology

     

    Guide to the Elimination of Catheter Associated Urinary Tract Infections

     

    • “It is well known that biofilms containing microorganisms can develop intraluminally or extraluminally in urinary catheters. A technological innovation that may prevent biofilm formation is a logical goal for reducing risk of CAUTI."

    • “A study performed at the Nebraska Medical Center looked at infection outcomes associated with the implementation of a silver alloy/hydrogel-coated urinary catheter. The study observed a significant decline in CAUTI rates."

    • “A randomized crossover trial involving silver-coated catheters also demonstrated a decline in infection outcomes among those receiving the coated catheter. The risk of infection declined by 21% among study wards randomized to silver-coated catheters, and by 32% among patients in whom silver-coated catheters were used on the wards.”


    Wound, Ostomy, and Continence Nurses Society

    Nursing Intervention to Reduce the Risk of Catheter Associated Urinary Tract Infection

    Results:

    “We found robust evidence supporting insertion of a silver alloy-coated catheter to reduce the risk of CAUTI for up to 2 weeks in adult patients managed by short term indwelling catheterization.”

    Strength of Evidence: Level 1


    Journal of the American Medical Association - 2002

    What Practices will most Improve Patient Safety? - Evidence-Based Medicine Meets Patient Safety

    Patient Safety Practices with High Strength of Evidence Regarding their Impact and Effectiveness

    Patient Safety Practices with High Strength of Evidence

    Patient Safety Target
    Hospital Acquired Urinary Tract Infections
    Patient Safety Practice
    Use of Silver-Alloy Coated catheters

    Cochrane Collaborative Review - 2008

    Types of urethral catheters for management of short-term voiding problems in hospitalized adults (Review)

     

    Author's conclusion

    “The results suggest that the use of silver alloy indwelling catheters for catheterizing hospitalized adults short term reduces the risk of catheter acquired urinary tract infection"



    European Association of Urology

     

    Guidelines on Urological Infections

    Summary of Recommendations (pg. 66)

    Silver alloy catheters significantly reduce the incidence of asymptomatic bacteriuria, but only for less than 1 week. There was some evidence of reduced risk for symptomatic UTI. Therefore they may be useful in some settings.

    Grade of Recommendation: B

    The British Department of Health and the Health Protection agency

     

    BARDEX® IC – silver alloy coated hydrogel catheters

    Basic research and development, validation and in use evaluations have shown benefits that should be available to NHS bodies to include as appropriate in their cleaning, hygiene or infection control protocols. Introduction into guidance should be considered by PASA, NHS Estates, MHRA or NICE, as appropriate (Recommendation 1).


    Infectious Disease Society of America

     

    In patients with short-term indwelling urethral catheterization, antimicrobial (silver alloy or antibiotic)–coated urinary catheters may be considered to reduce or delay the onset of CA-bacteriuria (B-II)


    • Click here for a PDF of the information above.
    • This site is intended for healthcare professionals. If you are a patient seeking more information regarding Catheter Associated Urinary Tract Infection (CAUTI) prevention, please consult your healthcare provider.